60 Chapter 3 18. Perez-Munuzuri A, Couce-Pico ML, Bana-Souto A, et al. Preclinical screening for retinopathy of prematurity risk using IGF1 levels at 3 weeks post-partum. PloS one 2014;9(2):e88781. doi: 10.1371/journal.pone.0088781 [published Online First: 2014/02/14] 19. Gortner L, Reiss I, Hilgendorff A. Bronchopulmonary dysplasia and intrauterine growth restriction. Lancet 2006;368(9529):28. doi: 10.1016/S0140-6736(06)68964-2 [published Online First: 2006/07/04] 20. Kurata H, Ochiai M, Inoue H, et al. Inflammation in the neonatal period and intrauterine growth restriction aggravate bronchopulmonary dysplasia. Pediatr Neonatol 2019;60(5):496-503. doi: 10.1016/j.pedneo.2018.11.007 [published Online First: 2019/07/16] 21. Capoluongo E, Ameglio F, Zuppi C. Insulin-like growth factor-I and complications of prematurity: a focus on bronchopulmonary dysplasia. Clinical chemistry and laboratory medicine 2008;46(8):1061-66. 22. Jensen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth defects research Part A, Clinical and molecular teratology 2014;100(3):145-57. doi: 10.1002/bdra.23235 [published Online First: 2014/03/19] 23. Klevebro S, Hellgren G, Hansen-Pupp I, et al. Elevated levels of IL-6 and IGFBP-1 predict low serum IGF-1 levels during continuous infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants. Growth Horm IGF Res 2019;50:1-8. doi: 10.1016/j.ghir.2019.11.001 [published Online First: 2019/11/23] 24. Milanesi BG, Lima PA, Villela LD, et al. Assessment of early nutritional intake in preterm infants with bronchopulmonary dysplasia: a cohort study. Eur J Pediatr 2021 doi: 10.1007/s00431-02003912-0 [published Online First: 2021/01/04] 25. Kon IY, Shilina NM, Gmoshinskaya MV, et al. The study of breast milk IGF-1, leptin, ghrelin and adiponectin levels as possible reasons of high weight gain in breast-fed infants. Ann Nutr Metab 2014;65(4):317-23. doi: 10.1159/000367998 [published Online First: 2014/11/18] 26. Goelz R, Hihn E, Hamprecht K, et al. Effects of different CMV-heat-inactivation-methods on growth factors in human breast milk. Pediatr Res 2009;65(4):458-61. doi: 10.1203/ PDR.0b013e3181991f18 [published Online First: 2009/01/08] 27. HoeflichA, Meyer Z. Functional analysis of the IGF-system inmilk. Best Pract Res ClinEndocrinol Metab 2017;31(4):409-18. doi: 10.1016/j.beem.2017.10.002 [published Online First: 2017/12/10] 28. Peila C, Moro GE, Bertino E, et al. The Effect of Holder Pasteurization on Nutrients and Biologically-Active Components in Donor Human Milk: A Review. Nutrients 2016;8(8) doi: 10.3390/nu8080477 [published Online First: 2016/08/05] 29. Moro GE, Billeaud C, Rachel B, et al. Processing of Donor Human Milk: Update and Recommendations From the European Milk Bank Association (EMBA). Front Pediatr 2019;7:49. doi: 10.3389/fped.2019.00049 [published Online First: 2019/03/16] 30. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163(7):17239. doi: 10.1164/ajrccm.163.7.2011060 [published Online First: 2001/06/13] 31. Travers CP, Clark RH, Spitzer AR, et al. Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study. BMJ 2017;356:j1039. doi: 10.1136/ bmj.j1039 [published Online First: 2017/03/30] 32. Gidrewicz DA, Fenton TR. A systematic review and meta-analysis of the nutrient content of preterm and term breast milk. BMC Pediatr 2014;14:216. doi: 10.1186/1471-2431-14-216 [published Online First: 2014/09/02] 33. Boyce C, Watson M, Lazidis G, et al. Preterm human milk composition: a systematic literature review. Br J Nutr 2016;116(6):1033-45. doi: 10.1017/S0007114516003007 [published Online First: 2016/08/16]
RkJQdWJsaXNoZXIy MTk4NDMw